Long-Term Open-Label Solifenacin Treatment Associated with Persistence with Therapy in Patients with Overactive Bladder Syndrome

How widespread are the symptoms of an overactive bladder and how are they managed? A population‐based prevalence study

Ian Milsom, Paul Abrams, L. Cardozo et al. · British Journal of Urology · 2001 · 1.8K citations · Full text

Medicine, Internal Medicine, Urology +13

Randomized, double‐blind placebo‐ and tolterodine‐controlled trial of the once‐daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder

Christopher R. Chapple, Tomasz Rechberger, P. J. MEFFAN et al. · British Journal of Urology · 2004 · 371 citations

Medicine, Pharmacology, Urology +15

RANDOMIZED, DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF THE ONCE DAILY ANTIMUSCARINIC AGENT SOLIFENACIN SUCCINATE IN PATIENTS WITH OVERACTIVE BLADDER

L. Cardozo, M. LISEC, R. J. Millard et al. · The Journal of Urology · 2004 · 336 citations

Medicine, Pharmacology, Pharmacotherapy +17

ONCE DAILY CONTROLLED VERSUS IMMEDIATE RELEASE OXYBUTYNIN CHLORIDE FOR URGE URINARY INCONTINENCE

Rodney U. Anderson, D Mobley, Bruce Blank et al. · The Journal of Urology · 1999 · 294 citations

Medicine, Pharmacotherapy, Urology +16

Comorbidities associated with overactive bladder.

Jeanette S. Brown, William F. McGhan, Sudhansu Chokroverty · PubMed · 2000 · 252 citations

Medicine, Surgery, Urology +15